U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5580155801Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene MutationsActive, not recruitingNo Results AvailableProgranulin Mutation CarriersDrug: Nimodipinehttps://ClinicalTrials.gov/show/NCT01835665
5580255802The Effects of Exercise in Parkinson's DiseaseCompletedNo Results AvailableParkinson Disease 10Other: Active Exercise|Other: Passive Exercisehttps://ClinicalTrials.gov/show/NCT01835652
5580355803Vitamin D Supplementation in Glomerular DiseaseRecruitingNo Results AvailableFocal Segmental Glomerulosclerosis (FSGS)Dietary Supplement: Cholecalciferol, 2000 or 4000 IUs by mouth daily for 12 weekshttps://ClinicalTrials.gov/show/NCT01835639
5580455804Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell CarcinomaRecruitingNo Results AvailableLocally Advanced Basal Cell Carcinoma|Skin Cancer|Cutaneous MalignancyDrug: Vismodegib|Radiation: Radiation therapyhttps://ClinicalTrials.gov/show/NCT01835626
5580555805Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.RecruitingNo Results AvailableRheumatoid Arthritis (RA)Other: Biomarkers Measureshttps://ClinicalTrials.gov/show/NCT01835613
5580655806Suspension of Mechanical Ventilation in Ureteroscopic Lithotripsy Under General AnesthesiaNot yet recruitingNo Results AvailableHypercapnia|HypoxiaOther: PEEPhttps://ClinicalTrials.gov/show/NCT01835600
5580755807Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation in Subjects With Acute Myeloid Leukemia or Myelodysplastic SyndromesRecruitingNo Results AvailableLeukemia, Myeloid, Acute|Myelodysplastic SyndromesDrug: Oral Azacitidinehttps://ClinicalTrials.gov/show/NCT01835587
5580855808Cambodia Integrated HIV and Drug Prevention Implementation ProgramRecruitingNo Results AvailableHIVBehavioral: Contingency Cash Transfer|Behavioral: Contingency Cash Transferhttps://ClinicalTrials.gov/show/NCT01835574
5580955809Study to Evaluate Pharmacokinetics of Pomalidomide in Hepatically Impaired MalesCompletedNo Results AvailableClinical Pharmacology, Healthy Volunteer StudyDrug: Pomalidomide|Drug: Pomalidomidehttps://ClinicalTrials.gov/show/NCT01835561
5581055810NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNo Results AvailableAttention Deficit Hyperactivity Disorder (ADHD)Drug: NT0102|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01835548
5581155811Continued Safety and Performance of the TIVUS SystemActive, not recruitingNo Results AvailableHypertension, Resistant to Conventional TherapyDevice: TIVUShttps://ClinicalTrials.gov/show/NCT01835535
5581255812A Survey of Sexual Function in Schizophrenic PatientsWithdrawnNo Results AvailableSexual Dysfunctionhttps://ClinicalTrials.gov/show/NCT01835522
5581355813Group Intervention to Increase Physical Activity in Childhood Cancer SurvivorsCompletedNo Results AvailablePediatric CancerBehavioral: Intervention, Camp plus reunionshttps://ClinicalTrials.gov/show/NCT01835509
5581455814Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell DiseaseCompletedHas ResultsSickle Cell DiseaseDrug: single 1500 mg dose of Ferriproxhttps://ClinicalTrials.gov/show/NCT01835496
5581555815Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden TestCompletedNo Results AvailableFactor V Leiden|Factor II|Thrombosishttps://ClinicalTrials.gov/show/NCT01835483
5581655816Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in JapanActive, not recruitingNo Results AvailableJuvenile Idiopathic ArthritisDrug: Abatacepthttps://ClinicalTrials.gov/show/NCT01835470
5581755817Concentration/Meditation Limits InflammationCompletedNo Results AvailableAutoimmune DiseasesDrug: Lipopolysaccharide|Behavioral: Concentration/meditationhttps://ClinicalTrials.gov/show/NCT01835457
5581855818A Multicenter Research on the Effects of Substitution of Hospital Ward Care From Medical Doctors to Physician AssistantsCompletedNo Results AvailableSubstitution of CareOther: PA/MD modelhttps://ClinicalTrials.gov/show/NCT01835444
5581955819A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 DiabetCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 1Drug: insulin degludec/insulin aspart|Drug: insulin aspart|Drug: insulin detemir|Drug: insulin asparthttps://ClinicalTrials.gov/show/NCT01835431
5582055820Bedtime Administration of Amlodipine Versus LisinoprilNot yet recruitingNo Results AvailableHypertensionDrug: Amlodipinehttps://ClinicalTrials.gov/show/NCT01835418
5582155821LiquiBand Versus Dermabond Versus Sutures for Closure of Surgical WoundsRecruitingNo Results AvailableSurgical IncisionsDevice: LiquiBand Flex|Device: Dermabond Advanced|Device: Sutures (Prolene)https://ClinicalTrials.gov/show/NCT01835405
5582255822Neuroprotective Effects of Remote Ischemic Preconditioning During Infant Cardiac SurgeryRecruitingNo Results AvailableHeart Defects, CongenitalProcedure: Remote Ischemic Preconditioning|Other: Controlhttps://ClinicalTrials.gov/show/NCT01835392
5582355823Study of Oasis Ultra in Diabetic Foot UlcersCompletedHas ResultsDiabetic Foot UlcerDevice: Oasis|Other: Standardhttps://ClinicalTrials.gov/show/NCT01835379
5582455824[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01835366
5582555825High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)CompletedNo Results AvailablePlatelet ReactivityDrug: Prasugrel 100mg loading dose|Drug: Prasugrel 60mg loading dosehttps://ClinicalTrials.gov/show/NCT01835353
5582655826Breath Gas Measurement of Propofol During Anesthesia in Patients With Endourological ProceduresRecruitingNo Results AvailableUrological DiseaseDevice: Drug: Propofol Anesthesia Patients will undergo propofol anesthesia.https://ClinicalTrials.gov/show/NCT01835340
5582755827Cerebral Oxygen Monitoring During Surgery and Recovery After Surgery in Patients Having Lung SurgeryRecruitingNo Results AvailableCerebral Oxygen Desaturationhttps://ClinicalTrials.gov/show/NCT01835327
5582855828Compassionate Use of Stiripentol in Dravet SyndromeAvailableNo Results AvailableDravet SyndromeDrug: Stiripentolhttps://ClinicalTrials.gov/show/NCT01835314
5582955829Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since ImplantationActive, not recruitingNo Results AvailableIn-stent Coronary Artery Restenosishttps://ClinicalTrials.gov/show/NCT01835301
5583055830Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaNot yet recruitingNo Results AvailableAdult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute MyeloblastDrug: arsenic trioxide|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01835288

* Görseller ve İçerik tekif hakkına sahip olabilir